June 2003
Medical Device & Diagnostic Industry
Selected Contents
EDITOR'S
PAGE:
Sterling
Silver
COVER STORY
And
the Winners Are…
Stacey L. Bell
Medical
Design Excellence Awards 2003
PLASTICS
Advances
in Medical Plastics
Gregg Nighswonger
Device makers traditionally have had
simple demands of the medical plastics they use. While clarity is foremost,
durability and resistance to sterilization also remain key considerations. In
addition to providing exceptional material properties, the current
generation of advanced plastics and elastomers offers other benefits for
medical manufacturers. Among these are improved hemocompatibility, enhanced radiation
sterilization stability, and reduced allergy risks.

GLUCOSE
MONITORING
Toward Continuous Blood Glucose Monitoring
Albert P. Kretz and Donald Styblo
For
more-effective diabetes management, glucose monitoring should be minimally
invasive, continuous, unobtrusive, and informative. Meeting this goal requires
microminiature sensors and electronics. MEMS fabrication, new materials, and IC
assembly techniques are now making it a practical reality.
Sidebar: Flip-Chip
Processes Affect Size, Cost, and Reliability
WASHINGTON
WRAP-UP:
James G. Dickinson
Adding
Their ID to Devices Not Feasible, Makers Say
Last year’s medical
device legislation mandates that all medical devices bear the names of their
manufacturers. AdvaMed argues that this provision was intended to apply only to
reprocessed devices.
Plus:
- Are Illegal Imports OK for Diagnostics?
- AdvaMed Writes Ethics Code for Dealing with Doctors
- FDA Worries about Bone Cement Labeling
- Gynecare Intergel Withdrawn from Market
- New Guidance on Natural Rubber Latex
- FDA Explains Electronic Labeling Rule
NEWSTRENDS
- Europe Debates Device Definitions
- UTI Acquires Venusa Ltd.
- Americas Technical Center Focuses on Polymers R&D
- Using
Remote Patient Monitoring to Support Home Healthcare
- Producing Fibers That Mimic Spider Silk
- Microgel Polymer Beads Provide Gene Therapy Vehicle
- Illuminating Nanoparticles Could Be Used for Imaging and Gene Detection
Eight
Ways to Kill Innovation
Stephen B.
Wilcox
Medical device manufacturers are supposed to thrive on change. Why, then, do so many of them make innovation difficult?
REGULATORY OUTLOOK
When All Else Fails: Understanding the
Medical Devices Dispute Resolution Panel
Jeffrey K.
Shapiro
Hogan & Hartson LLP
It is rarely used and carries risks. But for sponsors who disagree with the
scientific basis on which their product was rejected by FDA reviewers, the
dispute resolution panel may be an effective option.





